Zelira Therapeutics Limited (OTCMKTS:ZLDAF – Get Free Report) shares fell 6% during trading on Thursday . The company traded as low as $0.33 and last traded at $0.33. 200 shares were traded during trading, a decline of 20% from the average session volume of 250 shares. The stock had previously closed at $0.35.
Zelira Therapeutics Stock Performance
The stock has a 50-day simple moving average of $0.39 and a 200 day simple moving average of $0.45.
About Zelira Therapeutics
Zelira Therapeutics Limited, a bio-pharmaceutical company, engages in the research, development, and commercialization of cannabinoid-based medicines for the treatment of various medical conditions in Australia and the United States. The company offers formulations under the HOPE brand in Australia, Washington, Pennsylvania, and Louisiana, as well as develops Zenivol, a cannabinoid-based medicine for treatment of chronic insomnia.
Featured Stories
- Five stocks we like better than Zelira Therapeutics
- Unveiling The Power Of VWAP: A Key Indicator For Traders
- Market Momentum: 3 Stocks Poised for Significant Breakouts
- Why Special Dividends Can be a Delightful Surprise for Income Investors
- Kinder Morgan’s Uptrend is Only Half Over: New Highs Are Coming
- What is Short Interest? How to Use It
- Momentum Builders: 3 Stocks Positioned to Shine This Quarter
Receive News & Ratings for Zelira Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zelira Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
